Compounds > lutetium
Page last updated: 2024-08-22

lutetium and pentetic acid

lutetium has been researched along with pentetic acid in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's8 (38.10)29.6817
2010's11 (52.38)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Bauer, M; Krause, W; Muschick, P; Press, WR; Schuhmann-Giampieri, G1
Brechbiel, MW; Chappell, LL; Dadachova, E; Garmestani, K; Ma, D; Milenic, DE; Schlom, J; Yordanov, A1
Bernard, BF; Breeman, WA; de Jong, M; Erion, JL; Krenning, EP; van der Wansem, K; van Gameren, A; Visser, TJ1
Boerman, OC; Brouwers, AH; Corstens, FH; Frielink, C; Oosterwijk, E; Oyen, WJ; van Eerd, JE1
Blomquist, E; Bruskin, A; Carlsson, J; Gedda, L; Orlova, A; Sundberg, AL; Tolmachev, V1
de Jong, M; Esser, JP; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R1
Brechbiel, MW; Davis, ID; Kelly, MP; Lee, FT; Lee, ST; Scott, AM; Smyth, FE1
Rappel, C; Schaumlöffel, D1
Aarts, F; Bleichrodt, RP; Boerman, OC; de Jong, GM; Hendriks, T; Heskamp, S1
Decristoforo, C; Diederen, E; Dobrozemsky, G; Helbok, A; Prassl, R; Rangger, C; Stark, B; von Guggenberg, E1
Bigner, DD; Hens, M; Vaidyanathan, G; Zalutsky, MR; Zhao, XG1
Bleichrodt, RP; Boerman, OC; de Jong, GM; Eek, A; Hendriks, T; Oyen, WJ1
Cherepanov, VN; Ermolina, EG; Kuznetsova, RT; Sundholm, D; Valiev, RR1
Breeman, WA; Chan, HS; de Blois, E; de Zanger, R; Konijnenberg, M1
Choi, SJ; Hong, YD; Kim, HS; Lee, SY1
Dash, A; Gamre, N; Kameswaran, M; Pandey, U; Sarma, HD; Vimalnath, KV1
Dash, A; Gamre, N; Lohar, SP; Pandey, U1
Kruszewski, M; Wójciuk, G1
Albert, N; Bartenstein, P; Böning, G; Fiedler, L; Gildehaus, FJ; Gosewisch, A; Kellner, M; Lindner, S; Oos, R; Reulen, HJ; Zeidler, R1
Ahmad, MR; Akbar, MU; Ayub, N; Bokhari, TH; Roohi, S; Sohaib, M; Zia, KM1
Dahlbom, M; Reiter, RE; Tsai, WK; Wu, AM; Zettlitz, KA1

Reviews

2 review(s) available for lutetium and pentetic acid

ArticleYear
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
    Best practice & research. Clinical gastroenterology, 2005, Volume: 19, Issue:4

    Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Patient Selection; Pentetic Acid; Peptides, Cyclic; Quality of Life; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Peptide; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Yttrium Radioisotopes

2005
Effectiveness of quenchers to reduce radiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory peptides. Maintaining radiochemical purity as measured by HPLC.
    Current topics in medicinal chemistry, 2012, Volume: 12, Issue:23

    Topics: Chelating Agents; Chromatography, High Pressure Liquid; Excipients; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Lutetium; Methionine; Pentetic Acid; Peptides; Protein Stability; Radioactivity; Radiometry; Radiopharmaceuticals

2012

Other Studies

19 other study(ies) available for lutetium and pentetic acid

ArticleYear
Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
    Investigative radiology, 1996, Volume: 31, Issue:8

    Topics: Animals; Biological Products; Bismuth; Bone and Bones; Cerium; Chelating Agents; Chemical Phenomena; Chemistry, Physical; Contrast Media; Dysprosium; Erythrocytes; Humans; Lanthanum; Lead; Liver; Lutetium; Minerals; Organometallic Compounds; Osmolar Concentration; Partial Thromboplastin Time; Pentetic Acid; Phantoms, Imaging; Praseodymium; Protein Binding; Rabbits; Radiographic Image Enhancement; Rats; Tissue Distribution; Tomography, X-Ray Computed; Viscosity; Ytterbium

1996
In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications.
    Nuclear medicine and biology, 2002, Volume: 29, Issue:4

    Topics: Adenocarcinoma; Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Isothiocyanates; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Whole-Body Counting; Xenograft Model Antitumor Assays

2002
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:2

    Topics: Animals; Bone Marrow; Femur; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Kidney; Lutetium; Male; Octreotide; Organ Specificity; Organometallic Compounds; Pentetic Acid; Radiation-Protective Agents; Radioisotopes; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution

2003
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes

2004
[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
    Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:2

    Topics: Animals; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Epidermal Growth Factor; Glioblastoma; Humans; Lutetium; Mice; Mice, Inbred Strains; Pentetic Acid; Protein Binding; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution

2004
Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
    The Prostate, 2009, Jan-01, Volume: 69, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Radiation; Enzyme Inhibitors; ErbB Receptors; Humans; Isothiocyanates; Lutetium; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pentetic Acid; Phosphorylation; Prostatic Neoplasms; Quinazolines; Radiation-Sensitizing Agents; Radioimmunotherapy; Radioisotopes; Taxoids; Tyrphostins; Xenograft Model Antitumor Assays

2009
Absolute peptide quantification by lutetium labeling and nanoHPLC-ICPMS with isotope dilution analysis.
    Analytical chemistry, 2009, Jan-01, Volume: 81, Issue:1

    Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Insulin; Isotope Labeling; Lutetium; N-Formylmethionine Leucyl-Phenylalanine; Nanotechnology; Pentetic Acid; Peptides; Radioisotopes; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization

2009
Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental model.
    The British journal of surgery, 2009, Volume: 96, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Body Weight; Cell Line, Tumor; Colonic Neoplasms; Lutetium; Male; Neoplasm Recurrence, Local; Neoplasm Transplantation; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rats; Tumor Burden

2009
Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.
    Journal of liposome research, 2010, Volume: 20, Issue:3

    Topics: Animals; Gallium Radioisotopes; Indium Radioisotopes; Isotope Labeling; Liposomes; Lutetium; Magnetic Resonance Imaging; Nanoparticles; Organotechnetium Compounds; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Tomography, Emission-Computed, Single-Photon

2010
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
    Nuclear medicine and biology, 2010, Volume: 37, Issue:7

    Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; ErbB Receptors; Flow Cytometry; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Isothiocyanates; Lutetium; Mice; Mice, Inbred BALB C; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Stereoisomerism; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010
Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer.
    The British journal of surgery, 2011, Volume: 98, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Lutetium; Male; Neoplasm Transplantation; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rats; Tumor Cells, Cultured

2011
Computational and experimental studies of the electronic excitation spectra of EDTA and DTPA substituted tetraphenylporphyrins and their Lu complexes.
    Journal of molecular modeling, 2013, Volume: 19, Issue:11

    Topics: Edetic Acid; Electrons; Lutetium; Models, Chemical; Models, Molecular; Pentetic Acid; Porphyrins; Quantum Theory; Spectrum Analysis

2013
Synthesis and application of a novel cysteine-based DTPA-NCS for targeted radioimmunotherapy.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:3

    Topics: Animals; Antibodies, Monoclonal, Humanized; Cetuximab; Chemistry Techniques, Synthetic; Cysteine; Female; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Pentetic Acid; Radioimmunotherapy; Radioisotopes

2013
Evaluation of (177)Lu-CHX-A''-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2016, Volume: 114

    Topics: Animals; Bevacizumab; Cell Line, Tumor; Humans; Immunoconjugates; Lutetium; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; U937 Cells; Vascular Endothelial Growth Factor A

2016
A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2017, Volume: 127

    Topics: Chelating Agents; Drug Stability; Durapatite; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; In Vitro Techniques; Lutetium; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Trace Elements

2017
[DTPA-(PABn)-Leu5]-des-acyl ghrelin(1-5) as a new carrier of radionuclides and potential precursor of radiopharmaceuticals.
    Nuclear medicine communications, 2018, Volume: 39, Issue:2

    Topics: Amino Acid Sequence; Cell Line, Tumor; Drug Stability; Ghrelin; Humans; Isotope Labeling; Lutetium; Oligopeptides; Pentetic Acid; Radiochemistry; Radioisotopes; Radiopharmaceuticals

2018
Evaluation of
    Nuclear medicine and biology, 2018, Volume: 60

    Topics: A549 Cells; Animals; Carbonic Anhydrases; Female; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Lutetium; Mice; Pentetic Acid; Radiochemistry; Radioimmunotherapy; Radioisotopes; Tissue Distribution

2018
Radiosynthesis, radiochemical, and biological characterization of
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:9

    Topics: Animals; Drug Stability; Humans; Lutetium; Male; Mice; Pentetic Acid; Rabbits; Radioisotopes; Radiopharmaceuticals; Tissue Distribution

2019
Evaluation of [
    Molecular imaging and biology, 2020, Volume: 22, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Radiation; GPI-Linked Proteins; Iodine Radioisotopes; Lutetium; Male; Mice; Neoplasm Proteins; Pentetic Acid; Prostatic Neoplasms; Radioimmunotherapy; Radioisotopes; Radiometry; Survival Analysis; Tissue Distribution

2020